Alliancebernstein L.P. Astrazeneca PLC Transaction History

Alliancebernstein L.P.

$287 Billion
Q3 2024

A detailed history of Alliancebernstein L.P. transactions in Astrazeneca PLC stock. As of the latest transaction made, Alliancebernstein L.P. holds 1,878,356 shares of AZN stock, worth $123 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

1,878,356

Previous 1,900,020 1.14%

Holding current value

$123 Million

Previous $148 Million 1.23%

% of portfolio

0.05%

Previous 0.05%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$76.67 - $87.62 $1.66 Million - $1.9 Million	-21,664 Reduced 1.14%	1,878,356 $146 Million
Q2 2024 Aug 14, 2024	SELL	$66.81 - $80.83 $18.4 Million - $22.2 Million	-274,863 Reduced 12.64%	1,900,020 $148 Million
Q1 2024 May 14, 2024	BUY	$61.03 - $69.57 $42.4 Million - $48.3 Million	694,673 Added 46.93%	2,174,883 $147 Million
Q4 2023 Feb 14, 2024	SELL	$61.89 - $69.28 $3.43 Million - $3.84 Million	-55,439 Reduced 3.61%	1,480,210 $99.7 Million
Q3 2023 Nov 14, 2023	BUY	$64.85 - $71.7 $86.6 Million - $95.7 Million	1,334,911 Added 665.0%	1,535,649 $104 Million
Q2 2023 Aug 15, 2023	BUY	$69.91 - $75.81 $4.99 Million - $5.41 Million	71,415 Added 55.22%	200,738 $14.4 Million
Q1 2023 May 15, 2023	SELL	$63.15 - $71.6 $3.94 Million - $4.46 Million	-62,314 Reduced 32.52%	129,323 $8.98 Million
Q4 2022 Feb 14, 2023	SELL	$54.21 - $70.44 $6.01 Million - $7.81 Million	-110,925 Reduced 36.66%	191,637 $13 Million
Q3 2022 Nov 15, 2022	SELL	$53.02 - $135.75 $7.73 Million - $19.8 Million	-145,873 Reduced 32.53%	302,562 $16.6 Million
Q2 2022 Aug 15, 2022	SELL	$59.26 - $71.14 $79.7 Million - $95.7 Million	-1,344,946 Reduced 74.99%	448,435 $29.6 Million
Q1 2022 May 13, 2022	SELL	$55.72 - $67.12 $76 Million - $91.5 Million	-1,363,684 Reduced 43.19%	1,793,381 $119 Million
Q4 2021 Feb 14, 2022	BUY	$54.02 - $63.83 $3.9 Million - $4.61 Million	72,225 Added 2.34%	3,157,065 $184 Million
Q3 2021 Nov 10, 2021	SELL	$55.56 - $60.79 $60.8 Million - $66.5 Million	-1,093,833 Reduced 26.18%	3,084,840 $185 Million
Q2 2021 Jul 30, 2021	BUY	$48.42 - $60.18 $189 Million - $234 Million	3,893,799 Added 1366.85%	4,178,673 $250 Million
Q1 2021 May 06, 2021	BUY	$47.16 - $54.44 $12.7 Million - $14.7 Million	270,014 Added 1817.05%	284,874 $14.2 Million
Q4 2020 Feb 08, 2021	SELL	$48.52 - $58.02 $398,203 - $476,170	-8,207 Reduced 35.58%	14,860 $743,000
Q3 2020 Nov 12, 2020	SELL	$53.07 - $61.1 $4.52 Million - $5.21 Million	-85,228 Reduced 78.7%	23,067 $1.26 Million
Q2 2020 Aug 13, 2020	BUY	$43.1 - $55.31 $1.23 Million - $1.58 Million	28,652 Added 35.98%	108,295 $5.73 Million
Q1 2020 May 14, 2020	BUY	$37.79 - $51.33 $747,561 - $1.02 Million	19,782 Added 33.05%	79,643 $3.56 Million
Q4 2019 Feb 18, 2020	BUY	$42.46 - $50.46 $422,944 - $502,632	9,961 Added 19.96%	59,861 $2.99 Million
Q3 2019 Nov 14, 2019	SELL	$40.12 - $45.47 $2.56 Million - $2.9 Million	-63,698 Reduced 56.07%	49,900 $2.22 Million
Q2 2019 Aug 14, 2019	BUY	$37.28 - $41.68 $1.22 Million - $1.37 Million	32,773 Added 40.55%	113,598 $4.69 Million
Q1 2019 May 14, 2019	SELL	$35.49 - $43.02 $226,603 - $274,682	-6,385 Reduced 7.32%	80,825 $3.27 Million
Q4 2018 Feb 13, 2019	SELL	$36.86 - $41.49 $41.7 Million - $46.9 Million	-1,129,998 Reduced 92.84%	87,210 $3.31 Million
Q3 2018 Nov 08, 2018	SELL	$34.76 - $39.72 $7.46 Million - $8.53 Million	-214,675 Reduced 14.99%	1,217,208 $48.2 Million
Q2 2018 Aug 13, 2018	BUY	$34.55 - $37.05 $46.9 Million - $50.3 Million	1,356,811 Added 1807.35%	1,431,883 $50.3 Million
Q1 2018 May 14, 2018	BUY	$32.97 - $36.63 $2.48 Million - $2.75 Million	75,072 New	75,072 $2.63 Million

Others Institutions Holding AZN

# of Institutions

1,359

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $203B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account

Alliancebernstein L.P. Astrazeneca PLC Transaction History